PRNewsWire
27 Feb 2026, 14:20 UTC · 29w ago
Verdict
Headline takes no side. We score RGNX −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities class action lawsuit following FDA clinical holds on two gene therapy trials and a significant stock price drop.
More negative than 76% of ticker scores this week
The company is mentioned as being under investigation for potential claims in a securities class action.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 76% of ticker scores this week
The company is mentioned as being under investigation for potential claims in a securities class action.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
34m ago
−14.3%
Price agrees with the score
$7.50 vs $8.75 close before publication (Feb 26) · not market-adjusted
RGNX chart →
